Novel motif:40
From FANTOM5_SSTAR
name: | motif40_ATGCGGAGGAG |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0090192 | regulation of glomerulus development | 1.302533e-11 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 2.475004e-11 |
GO:0072298 | regulation of metanephric glomerulus development | 5.466977e-11 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 5.886295e-10 |
GO:0007522 | visceral muscle development | 2.749827e-8 |
GO:0072110 | glomerular mesangial cell proliferation | 9.082091e-8 |
GO:0097116 | gephyrin clustering | 1.526029e-7 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 4.383875e-7 |
GO:0097118 | neuroligin clustering | 5.139192e-7 |
GO:0071072 | negative regulation of phospholipid biosynthetic process | 5.203618e-7 |
GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 5.314211e-7 |
GO:0072111 | cell proliferation involved in kidney development | 5.571552e-7 |
GO:0030157 | pancreatic juice secretion | 7.037974e-7 |
GO:0071071 | regulation of phospholipid biosynthetic process | 7.917654e-7 |
GO:0018277 | protein deamination | 8.171732e-7 |
GO:0097119 | postsynaptic density protein 95 clustering | 1.018371e-6 |
GO:0097104 | postsynaptic membrane assembly | 1.018371e-6 |
GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 1.040327e-6 |
GO:0071506 | cellular response to mycophenolic acid | 1.040327e-6 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 1.263754e-6 |
GO:0010624 | regulation of Schwann cell proliferation | 1.335047e-6 |
GO:0001662 | behavioral fear response | 2.864703e-6 |
GO:0006356 | regulation of transcription from RNA polymerase I promoter | 3.408324e-6 |
GO:0072125 | negative regulation of glomerular mesangial cell proliferation | 3.633294e-6 |
GO:0072109 | glomerular mesangium development | 3.633294e-6 |
GO:0090399 | replicative senescence | 3.740750e-6 |
GO:0042088 | T-helper 1 type immune response | 4.092504e-6 |
GO:0043084 | penile erection | 4.281342e-6 |
GO:0006449 | regulation of translational termination | 4.461284e-6 |
GO:0060683 | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling | 4.950771e-6 |
GO:0002209 | behavioral defense response | 5.915705e-6 |
GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process | 5.979982e-6 |
GO:0043064 | flagellum organization | 6.904873e-6 |
GO:2000016 | negative regulation of determination of dorsal identity | 7.509501e-6 |
GO:0007288 | sperm axoneme assembly | 7.669265e-6 |
GO:0060251 | regulation of glial cell proliferation | 8.779819e-6 |
GO:0061003 | positive regulation of dendritic spine morphogenesis | 8.819624e-6 |
GO:0010511 | regulation of phosphatidylinositol biosynthetic process | 8.819624e-6 |
GO:0010225 | response to UV-C | 1.163635e-5 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 1.240904e-5 |
GO:0030509 | BMP signaling pathway | 1.375703e-5 |
GO:0071353 | cellular response to interleukin-4 | 1.738534e-5 |
GO:0060999 | positive regulation of dendritic spine development | 1.865514e-5 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 1.888788e-5 |
GO:0043586 | tongue development | 2.247974e-5 |
GO:0070861 | regulation of protein exit from endoplasmic reticulum | 2.249820e-5 |
GO:0021562 | vestibulocochlear nerve development | 2.770328e-5 |
GO:0035461 | vitamin transmembrane transport | 2.934937e-5 |
GO:0016574 | histone ubiquitination | 2.935478e-5 |
GO:0060005 | vestibular reflex | 2.952092e-5 |
GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 3.158205e-5 |
GO:0071584 | negative regulation of zinc ion import | 3.207831e-5 |
GO:0090281 | negative regulation of calcium ion import | 3.207831e-5 |
GO:0071895 | odontoblast differentiation | 3.262737e-5 |
GO:0048332 | mesoderm morphogenesis | 3.288738e-5 |
GO:0070831 | basement membrane assembly | 3.376910e-5 |
GO:0035356 | cellular triglyceride homeostasis | 3.462916e-5 |
GO:0043923 | positive regulation by host of viral transcription | 3.571527e-5 |
GO:0048708 | astrocyte differentiation | 3.572778e-5 |
GO:0005983 | starch catabolic process | 3.575159e-5 |
GO:0019227 | neuronal action potential propagation | 3.848613e-5 |
GO:0032231 | regulation of actin filament bundle assembly | 4.011041e-5 |
GO:0042093 | T-helper cell differentiation | 4.292481e-5 |
GO:0002528 | regulation of vascular permeability involved in acute inflammatory response | 4.416516e-5 |
GO:0006398 | histone mRNA 3'-end processing | 4.599032e-5 |
GO:0045843 | negative regulation of striated muscle tissue development | 4.636150e-5 |
GO:0072179 | nephric duct formation | 5.054568e-5 |
GO:0090183 | regulation of kidney development | 5.274499e-5 |
GO:0008334 | histone mRNA metabolic process | 5.406141e-5 |
GO:0001707 | mesoderm formation | 5.454337e-5 |
GO:0042596 | fear response | 5.483816e-5 |
GO:0090128 | regulation of synapse maturation | 5.540344e-5 |
GO:0003406 | retinal pigment epithelium development | 5.848610e-5 |
GO:0090086 | negative regulation of protein deubiquitination | 6.550673e-5 |
GO:0072300 | positive regulation of metanephric glomerulus development | 6.684892e-5 |
GO:0071625 | vocalization behavior | 6.856483e-5 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 6.856483e-5 |
GO:0002309 | T cell proliferation involved in immune response | 6.954603e-5 |
GO:0043543 | protein acylation | 7.198600e-5 |
GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway | 7.807077e-5 |
GO:0048752 | semicircular canal morphogenesis | 8.723499e-5 |
GO:0001886 | endothelial cell morphogenesis | 8.811918e-5 |
GO:0030828 | positive regulation of cGMP biosynthetic process | 8.896333e-5 |
GO:0033233 | regulation of protein sumoylation | 9.428629e-5 |
GO:0046814 | virion attachment, binding of host cell surface coreceptor | 9.770113e-5 |
GO:0060923 | cardiac muscle cell fate commitment | 1.049939e-4 |
GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity | 1.143964e-4 |
GO:0008292 | acetylcholine biosynthetic process | 1.179974e-4 |
GO:0017145 | stem cell division | 1.218644e-4 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 1.288917e-4 |
GO:0055107 | Golgi to secretory granule transport | 1.366099e-4 |
GO:2000370 | positive regulation of clathrin-mediated endocytosis | 1.398542e-4 |
GO:0014739 | positive regulation of muscle hyperplasia | 1.398542e-4 |
GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus | 1.577174e-4 |
GO:0043503 | skeletal muscle fiber adaptation | 1.737929e-4 |
GO:0006473 | protein acetylation | 1.742581e-4 |
GO:0010835 | regulation of protein ADP-ribosylation | 1.779746e-4 |
GO:0030223 | neutrophil differentiation | 1.904540e-4 |
GO:0032793 | positive regulation of CREB transcription factor activity | 1.982685e-4 |
GO:0006335 | DNA replication-dependent nucleosome assembly | 2.035334e-4 |
GO:0033092 | positive regulation of immature T cell proliferation in thymus | 2.096310e-4 |
GO:0061153 | trachea gland development | 2.106228e-4 |
GO:0070079 | histone H4-R3 demethylation | 2.159947e-4 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 2.159947e-4 |
GO:0070078 | histone H3-R2 demethylation | 2.159947e-4 |
GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter | 2.159947e-4 |
GO:0071934 | thiamine transmembrane transport | 2.186051e-4 |
GO:0034766 | negative regulation of ion transmembrane transport | 2.186051e-4 |
GO:0003329 | pancreatic PP cell fate commitment | 2.305044e-4 |
GO:0003326 | pancreatic A cell fate commitment | 2.305044e-4 |
GO:0006513 | protein monoubiquitination | 2.334914e-4 |
GO:0071866 | negative regulation of apoptosis in bone marrow | 2.416458e-4 |
GO:0071864 | positive regulation of cell proliferation in bone marrow | 2.416458e-4 |
GO:0060710 | chorio-allantoic fusion | 2.557586e-4 |
GO:0045662 | negative regulation of myoblast differentiation | 2.584833e-4 |
GO:0006562 | proline catabolic process | 2.609222e-4 |
GO:2000573 | positive regulation of DNA biosynthetic process | 2.797593e-4 |
GO:0042593 | glucose homeostasis | 2.807288e-4 |
GO:0003180 | aortic valve morphogenesis | 2.948459e-4 |
GO:0070145 | mitochondrial asparaginyl-tRNA aminoacylation | 3.029322e-4 |
GO:0033490 | cholesterol biosynthetic process via lathosterol | 3.029322e-4 |
GO:0043462 | regulation of ATPase activity | 3.039442e-4 |
GO:0061032 | visceral serous pericardium development | 3.091870e-4 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 3.091870e-4 |
GO:2000597 | positive regulation of optic nerve formation | 3.091870e-4 |
GO:0061360 | optic chiasma development | 3.091870e-4 |
GO:0006173 | dADP biosynthetic process | 3.091870e-4 |
GO:0021633 | optic nerve structural organization | 3.091870e-4 |
GO:0021650 | vestibulocochlear nerve formation | 3.091870e-4 |
GO:0035799 | ureter maturation | 3.091870e-4 |
GO:0032656 | regulation of interleukin-13 production | 3.109006e-4 |
GO:0019064 | viral envelope fusion with host membrane | 3.377556e-4 |
GO:0035566 | regulation of metanephros size | 3.631237e-4 |
GO:0014807 | regulation of somitogenesis | 3.631237e-4 |
GO:0071539 | protein localization to centrosome | 3.632372e-4 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 3.632372e-4 |
GO:0072215 | regulation of metanephros development | 3.653160e-4 |
GO:0050434 | positive regulation of viral transcription | 3.740821e-4 |
GO:0016180 | snRNA processing | 3.750919e-4 |
GO:0045657 | positive regulation of monocyte differentiation | 3.789750e-4 |
GO:0016073 | snRNA metabolic process | 4.007521e-4 |
GO:0033083 | regulation of immature T cell proliferation | 4.040570e-4 |
GO:0051315 | attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation | 4.055653e-4 |
GO:0010626 | negative regulation of Schwann cell proliferation | 4.637630e-4 |
GO:0048103 | somatic stem cell division | 4.639385e-4 |
GO:0060816 | random inactivation of X chromosome | 4.641753e-4 |
GO:0061113 | pancreas morphogenesis | 4.641753e-4 |
GO:0061157 | mRNA destabilization | 4.700238e-4 |
GO:0045090 | retroviral genome replication | 4.700238e-4 |
GO:0010609 | posttranscriptional regulation of gene expression by mRNA localization | 4.700238e-4 |
GO:0045063 | T-helper 1 cell differentiation | 4.714218e-4 |
GO:0001941 | postsynaptic membrane organization | 4.938947e-4 |
GO:0035518 | histone H2A monoubiquitination | 5.035574e-4 |
GO:0007625 | grooming behavior | 5.128823e-4 |
GO:0097117 | guanylate kinase-associated protein clustering | 5.237476e-4 |
GO:0097114 | N-methyl-D-aspartate receptor clustering | 5.237476e-4 |
GO:0097112 | gamma-aminobutyric acid receptor clustering | 5.237476e-4 |
GO:0010719 | negative regulation of epithelial to mesenchymal transition | 5.287308e-4 |
GO:0021943 | formation of radial glial scaffolds | 5.322483e-4 |
GO:0033522 | histone H2A ubiquitination | 5.399053e-4 |
GO:0042450 | arginine biosynthetic process via ornithine | 5.707337e-4 |
GO:0010625 | positive regulation of Schwann cell proliferation | 5.869507e-4 |
GO:0050872 | white fat cell differentiation | 6.251007e-4 |
GO:0033602 | negative regulation of dopamine secretion | 6.592049e-4 |
GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing | 6.592049e-4 |
GO:0007259 | JAK-STAT cascade | 6.686222e-4 |
GO:0032856 | activation of Ras GTPase activity | 6.722154e-4 |
GO:0060253 | negative regulation of glial cell proliferation | 6.747876e-4 |
GO:0090129 | positive regulation of synapse maturation | 6.986124e-4 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 7.016784e-4 |
GO:0060020 | Bergmann glial cell differentiation | 7.201476e-4 |
GO:0034723 | DNA replication-dependent nucleosome organization | 7.464812e-4 |
GO:0060242 | contact inhibition | 7.464812e-4 |
GO:0032926 | negative regulation of activin receptor signaling pathway | 7.697205e-4 |
GO:0060252 | positive regulation of glial cell proliferation | 8.111393e-4 |
GO:0070127 | tRNA aminoacylation for mitochondrial protein translation | 8.151819e-4 |
GO:2000143 | negative regulation of transcription initiation, DNA-dependent | 8.353957e-4 |
GO:0019086 | late viral mRNA transcription | 8.353957e-4 |
GO:0060547 | negative regulation of necrotic cell death | 8.386187e-4 |
GO:0002051 | osteoblast fate commitment | 8.408720e-4 |
GO:0060561 | apoptosis involved in morphogenesis | 8.498757e-4 |
GO:0032674 | regulation of interleukin-5 production | 8.515350e-4 |
GO:0071504 | cellular response to heparin | 8.673378e-4 |
GO:0015809 | arginine transport | 9.143777e-4 |
GO:0042506 | tyrosine phosphorylation of Stat5 protein | 9.308785e-4 |
GO:0001823 | mesonephros development | 9.363386e-4 |
GO:0001974 | blood vessel remodeling | 9.756093e-4 |
GO:0097120 | receptor localization to synapse | 9.982535e-4 |
GO:0072578 | neurotransmitter-gated ion channel clustering | 9.982535e-4 |
GO:0006538 | glutamate catabolic process | 1.001753e-3 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 1.046168e-3 |
GO:0043313 | regulation of neutrophil degranulation | 1.048446e-3 |
GO:0070863 | positive regulation of protein exit from endoplasmic reticulum | 1.050432e-3 |
GO:0031063 | regulation of histone deacetylation | 1.064279e-3 |
GO:0009296 | flagellum assembly | 1.085352e-3 |
GO:0014053 | negative regulation of gamma-aminobutyric acid secretion | 1.093807e-3 |
GO:0010529 | negative regulation of transposition | 1.127764e-3 |
GO:0046532 | regulation of photoreceptor cell differentiation | 1.136964e-3 |
GO:0032092 | positive regulation of protein binding | 1.142044e-3 |
GO:0035418 | protein localization to synapse | 1.150247e-3 |
GO:0070574 | cadmium ion transmembrane transport | 1.159677e-3 |
GO:0030851 | granulocyte differentiation | 1.170333e-3 |
GO:0006475 | internal protein amino acid acetylation | 1.176654e-3 |
GO:0048168 | regulation of neuronal synaptic plasticity | 1.197469e-3 |
GO:0046533 | negative regulation of photoreceptor cell differentiation | 1.219956e-3 |
GO:0030382 | sperm mitochondrion organization | 1.232466e-3 |
GO:0051586 | positive regulation of dopamine uptake | 1.265007e-3 |
GO:0048210 | Golgi vesicle fusion to target membrane | 1.265007e-3 |
GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway | 1.269399e-3 |
GO:0003062 | regulation of heart rate by chemical signal | 1.292845e-3 |
GO:0043314 | negative regulation of neutrophil degranulation | 1.321230e-3 |
GO:0033088 | negative regulation of immature T cell proliferation in thymus | 1.360451e-3 |
GO:0097105 | presynaptic membrane assembly | 1.375768e-3 |
GO:0032862 | activation of Rho GTPase activity | 1.457884e-3 |
GO:0051497 | negative regulation of stress fiber assembly | 1.486599e-3 |
GO:0048635 | negative regulation of muscle organ development | 1.488738e-3 |
GO:0034389 | lipid particle organization | 1.566864e-3 |
GO:0006268 | DNA unwinding involved in replication | 1.649101e-3 |
GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process | 1.651775e-3 |
GO:0071585 | detoxification of cadmium ion | 1.672618e-3 |
GO:0048341 | paraxial mesoderm formation | 1.762535e-3 |
GO:0044258 | intestinal lipid catabolic process | 1.812468e-3 |
GO:0018350 | protein esterification | 1.812468e-3 |
GO:0009436 | glyoxylate catabolic process | 1.863372e-3 |
GO:0018364 | peptidyl-glutamine methylation | 1.863372e-3 |
GO:0003310 | pancreatic A cell differentiation | 1.894523e-3 |
GO:0072203 | cell proliferation involved in metanephros development | 1.896588e-3 |
GO:0030852 | regulation of granulocyte differentiation | 1.897906e-3 |
GO:0009299 | mRNA transcription | 1.923540e-3 |
GO:0060370 | susceptibility to T cell mediated cytotoxicity | 1.961365e-3 |
GO:0071503 | response to heparin | 2.002639e-3 |
GO:0045838 | positive regulation of membrane potential | 2.028364e-3 |
GO:0009186 | deoxyribonucleoside diphosphate metabolic process | 2.043034e-3 |
GO:0072178 | nephric duct morphogenesis | 2.067863e-3 |
GO:0019428 | allantoin biosynthetic process | 2.078544e-3 |
GO:0072176 | nephric duct development | 2.140381e-3 |
GO:0072498 | embryonic skeletal joint development | 2.216727e-3 |
GO:0051102 | DNA ligation involved in DNA recombination | 2.285060e-3 |
GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus | 2.304613e-3 |
GO:0090193 | positive regulation of glomerulus development | 2.304613e-3 |
GO:0045342 | MHC class II biosynthetic process | 2.336491e-3 |
GO:0070839 | divalent metal ion export | 2.336491e-3 |
GO:0006876 | cellular cadmium ion homeostasis | 2.336491e-3 |
GO:0043091 | L-arginine import | 2.336491e-3 |
GO:0032632 | interleukin-3 production | 2.336491e-3 |
GO:0015707 | nitrite transport | 2.336491e-3 |
GO:0006537 | glutamate biosynthetic process | 2.347959e-3 |
GO:0018205 | peptidyl-lysine modification | 2.409967e-3 |
GO:0000710 | meiotic mismatch repair | 2.415700e-3 |
GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 2.429072e-3 |
GO:0072075 | metanephric mesenchyme development | 2.442487e-3 |
GO:0051492 | regulation of stress fiber assembly | 2.480648e-3 |
GO:0030422 | production of siRNA involved in RNA interference | 2.513618e-3 |
GO:0050652 | dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 2.563003e-3 |
GO:0006408 | snRNA export from nucleus | 2.563003e-3 |
GO:0090311 | regulation of protein deacetylation | 2.620200e-3 |
GO:0007064 | mitotic sister chromatid cohesion | 2.659605e-3 |
GO:0014733 | regulation of skeletal muscle adaptation | 2.681639e-3 |
GO:0030853 | negative regulation of granulocyte differentiation | 2.696893e-3 |
GO:0001710 | mesodermal cell fate commitment | 2.735026e-3 |
GO:0046341 | CDP-diacylglycerol metabolic process | 2.852182e-3 |
GO:0090278 | negative regulation of peptide hormone secretion | 2.904743e-3 |
GO:0007221 | positive regulation of transcription of Notch receptor target | 2.926514e-3 |
GO:0006654 | phosphatidic acid biosynthetic process | 2.930173e-3 |
GO:0000115 | regulation of transcription involved in S phase of mitotic cell cycle | 2.944799e-3 |
GO:0071394 | cellular response to testosterone stimulus | 2.986137e-3 |
GO:0044356 | clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine | 3.005626e-3 |
GO:0060591 | chondroblast differentiation | 3.005721e-3 |
GO:0009084 | glutamine family amino acid biosynthetic process | 3.040491e-3 |
GO:0043268 | positive regulation of potassium ion transport | 3.077274e-3 |
GO:0021703 | locus ceruleus development | 3.099243e-3 |
GO:0006424 | glutamyl-tRNA aminoacylation | 3.099243e-3 |
GO:0010717 | regulation of epithelial to mesenchymal transition | 3.136981e-3 |
GO:0032233 | positive regulation of actin filament bundle assembly | 3.142503e-3 |
GO:0014037 | Schwann cell differentiation | 3.161350e-3 |
GO:0016573 | histone acetylation | 3.254275e-3 |
GO:0046473 | phosphatidic acid metabolic process | 3.254747e-3 |
GO:0050885 | neuromuscular process controlling balance | 3.278507e-3 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 3.314255e-3 |
GO:0051318 | G1 phase | 3.336546e-3 |
GO:0030262 | apoptotic nuclear change | 3.403263e-3 |
GO:0090400 | stress-induced premature senescence | 3.497736e-3 |
GO:0000432 | positive regulation of transcription from RNA polymerase II promoter by glucose | 3.619071e-3 |
GO:0033601 | positive regulation of mammary gland epithelial cell proliferation | 3.684431e-3 |
GO:0048733 | sebaceous gland development | 3.768045e-3 |
GO:0033081 | regulation of T cell differentiation in thymus | 3.851911e-3 |
GO:0051645 | Golgi localization | 3.903989e-3 |
GO:0045575 | basophil activation | 3.903989e-3 |
GO:0001694 | histamine biosynthetic process | 3.903989e-3 |
GO:0006431 | methionyl-tRNA aminoacylation | 3.936011e-3 |
GO:0002642 | positive regulation of immunoglobulin biosynthetic process | 3.936011e-3 |
GO:0018394 | peptidyl-lysine acetylation | 3.948908e-3 |
GO:0007080 | mitotic metaphase plate congression | 3.957585e-3 |
GO:0060684 | epithelial-mesenchymal cell signaling | 4.021976e-3 |
GO:0010390 | histone monoubiquitination | 4.034933e-3 |
GO:0002293 | alpha-beta T cell differentiation involved in immune response | 4.052673e-3 |
GO:0018393 | internal peptidyl-lysine acetylation | 4.068139e-3 |
GO:0002268 | follicular dendritic cell differentiation | 4.087137e-3 |
GO:0006172 | ADP biosynthetic process | 4.133641e-3 |
GO:0014044 | Schwann cell development | 4.185426e-3 |
GO:0021535 | cell migration in hindbrain | 4.225344e-3 |
GO:0031064 | negative regulation of histone deacetylation | 4.234625e-3 |
GO:0045655 | regulation of monocyte differentiation | 4.299610e-3 |
GO:0009153 | purine deoxyribonucleotide biosynthetic process | 4.308957e-3 |
GO:0051103 | DNA ligation involved in DNA repair | 4.446229e-3 |
GO:0043243 | positive regulation of protein complex disassembly | 4.494797e-3 |
GO:0043276 | anoikis | 4.497584e-3 |
GO:2000195 | negative regulation of female gonad development | 4.526033e-3 |
GO:0060123 | regulation of growth hormone secretion | 4.528627e-3 |
GO:0072537 | fibroblast activation | 4.567811e-3 |
GO:0003094 | glomerular filtration | 4.567811e-3 |
GO:0044342 | type B pancreatic cell proliferation | 4.610557e-3 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 4.610557e-3 |
GO:0035883 | enteroendocrine cell differentiation | 4.610557e-3 |
GO:0035710 | CD4-positive, alpha-beta T cell activation | 4.616615e-3 |
GO:0030844 | positive regulation of intermediate filament depolymerization | 4.618349e-3 |
GO:0052565 | response to defense-related host nitric oxide production | 4.618349e-3 |
GO:0022011 | myelination in peripheral nervous system | 4.674042e-3 |
GO:0032696 | negative regulation of interleukin-13 production | 4.696515e-3 |
GO:0046676 | negative regulation of insulin secretion | 4.731551e-3 |
GO:0090141 | positive regulation of mitochondrial fission | 4.739046e-3 |
GO:0000255 | allantoin metabolic process | 4.792655e-3 |
GO:0045217 | cell-cell junction maintenance | 4.799443e-3 |
GO:0003416 | endochondral bone growth | 5.004237e-3 |
GO:0050775 | positive regulation of dendrite morphogenesis | 5.073155e-3 |
GO:0071955 | recycling endosome to Golgi transport | 5.139710e-3 |
GO:0034499 | late endosome to Golgi transport | 5.139710e-3 |
GO:0010735 | positive regulation of transcription via serum response element binding | 5.188677e-3 |
GO:0045618 | positive regulation of keratinocyte differentiation | 5.215149e-3 |
GO:0007621 | negative regulation of female receptivity | 5.215149e-3 |
GO:0071557 | histone H3-K27 demethylation | 5.313797e-3 |
GO:0035574 | histone H4-K20 demethylation | 5.313797e-3 |
GO:0003417 | growth plate cartilage development | 5.325155e-3 |
GO:0048069 | eye pigmentation | 5.410907e-3 |
GO:2000194 | regulation of female gonad development | 5.442636e-3 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 5.442636e-3 |
GO:0007501 | mesodermal cell fate specification | 5.489727e-3 |
GO:2000272 | negative regulation of receptor activity | 5.511091e-3 |
GO:0072134 | nephrogenic mesenchyme morphogenesis | 5.648263e-3 |
GO:0002021 | response to dietary excess | 5.671288e-3 |
GO:0055026 | negative regulation of cardiac muscle tissue development | 5.715654e-3 |
GO:0031643 | positive regulation of myelination | 5.715654e-3 |
GO:0042723 | thiamine-containing compound metabolic process | 5.744665e-3 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 5.782911e-3 |
GO:0072095 | regulation of branch elongation involved in ureteric bud branching | 5.997758e-3 |
GO:0032796 | uropod organization | 6.030842e-3 |
GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus | 6.102296e-3 |
GO:0015747 | urate transport | 6.102296e-3 |
GO:0045078 | positive regulation of interferon-gamma biosynthetic process | 6.275305e-3 |
GO:0051081 | nuclear envelope disassembly | 6.340749e-3 |
GO:0006363 | termination of RNA polymerase I transcription | 6.364106e-3 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 6.547252e-3 |
GO:2000463 | positive regulation of excitatory postsynaptic membrane potential | 6.567666e-3 |
GO:0042780 | tRNA 3'-end processing | 6.570877e-3 |
GO:0031118 | rRNA pseudouridine synthesis | 6.570877e-3 |
GO:0051793 | medium-chain fatty acid catabolic process | 6.570877e-3 |
GO:0010571 | positive regulation of DNA replication involved in S phase | 6.570877e-3 |
GO:0019068 | virion assembly | 6.570877e-3 |
GO:0009065 | glutamine family amino acid catabolic process | 6.588716e-3 |
GO:2000369 | regulation of clathrin-mediated endocytosis | 6.658258e-3 |
GO:0008291 | acetylcholine metabolic process | 6.677592e-3 |
GO:0030224 | monocyte differentiation | 6.700670e-3 |
GO:0032714 | negative regulation of interleukin-5 production | 6.730148e-3 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 6.772625e-3 |
GO:0021932 | hindbrain radial glia guided cell migration | 6.793727e-3 |
GO:0060465 | pharynx development | 6.850650e-3 |
GO:0043990 | histone H2A-S1 phosphorylation | 6.850650e-3 |
GO:0034378 | chylomicron assembly | 6.850650e-3 |
GO:0035048 | splicing factor protein import into nucleus | 6.850650e-3 |
GO:0048050 | post-embryonic eye morphogenesis | 6.884026e-3 |
GO:0035417 | negative regulation of mitotic prometaphase | 6.884026e-3 |
GO:0003017 | lymph circulation | 7.012582e-3 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 7.099072e-3 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 7.118886e-3 |
GO:0060272 | embryonic skeletal joint morphogenesis | 7.147785e-3 |
GO:0035082 | axoneme assembly | 7.265085e-3 |
GO:0072136 | metanephric mesenchymal cell proliferation involved in metanephros development | 7.290728e-3 |
GO:0042989 | sequestering of actin monomers | 7.379067e-3 |
GO:0030037 | actin filament reorganization involved in cell cycle | 7.473363e-3 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 7.528959e-3 |
GO:0097090 | presynaptic membrane organization | 7.761125e-3 |
GO:0032108 | negative regulation of response to nutrient levels | 7.761125e-3 |
GO:0090161 | Golgi ribbon formation | 7.892124e-3 |
GO:0046349 | amino sugar biosynthetic process | 7.892124e-3 |
GO:0030220 | platelet formation | 8.013165e-3 |
GO:0060124 | positive regulation of growth hormone secretion | 8.086508e-3 |
GO:0006491 | N-glycan processing | 8.219190e-3 |
GO:0010159 | specification of organ position | 8.256448e-3 |
GO:0002086 | diaphragm contraction | 8.351428e-3 |
GO:0036006 | cellular response to macrophage colony-stimulating factor stimulus | 8.460586e-3 |
GO:0010034 | response to acetate | 8.465482e-3 |
GO:0070327 | thyroid hormone transport | 8.504408e-3 |
GO:0006379 | mRNA cleavage | 8.645547e-3 |
GO:0060070 | canonical Wnt receptor signaling pathway | 8.865042e-3 |
GO:0060847 | endothelial cell fate specification | 8.916203e-3 |
GO:0060220 | camera-type eye photoreceptor cell fate commitment | 8.916203e-3 |
GO:0043111 | replication fork arrest | 8.916203e-3 |
GO:0048074 | negative regulation of eye pigmentation | 8.916203e-3 |
GO:0035814 | negative regulation of renal sodium excretion | 8.978761e-3 |
GO:0090084 | negative regulation of inclusion body assembly | 8.995152e-3 |
GO:0046782 | regulation of viral transcription | 9.047334e-3 |
GO:0060376 | positive regulation of mast cell differentiation | 9.212880e-3 |
GO:0015884 | folic acid transport | 9.233405e-3 |
GO:0071732 | cellular response to nitric oxide | 9.233405e-3 |
GO:0060375 | regulation of mast cell differentiation | 9.314637e-3 |
GO:0046684 | response to pyrethroid | 9.314637e-3 |
GO:0019344 | cysteine biosynthetic process | 9.314637e-3 |
GO:0046604 | positive regulation of mitotic centrosome separation | 9.341902e-3 |
GO:0000379 | tRNA-type intron splice site recognition and cleavage | 9.341902e-3 |
GO:0006353 | transcription termination, DNA-dependent | 9.495381e-3 |
GO:0051095 | regulation of helicase activity | 9.495548e-3 |
GO:0048194 | Golgi vesicle budding | 9.623803e-3 |
GO:0045064 | T-helper 2 cell differentiation | 9.640483e-3 |
GO:0070383 | DNA cytosine deamination | 9.640483e-3 |
GO:0002315 | marginal zone B cell differentiation | 9.640483e-3 |
GO:0030073 | insulin secretion | 9.655522e-3 |
GO:0006622 | protein targeting to lysosome | 9.764266e-3 |
GO:0030825 | positive regulation of cGMP metabolic process | 9.902684e-3 |
GO:0060262 | negative regulation of N-terminal protein palmitoylation | 9.931340e-3 |
GO:0021547 | midbrain-hindbrain boundary initiation | 9.931340e-3 |
GO:0021501 | prechordal plate formation | 9.931340e-3 |
GO:0043949 | regulation of cAMP-mediated signaling | 9.952702e-3 |
GO:0000027 | ribosomal large subunit assembly | 1.000080e-2 |
GO:0016584 | nucleosome positioning | 1.039515e-2 |
GO:0060708 | spongiotrophoblast differentiation | 1.044299e-2 |
GO:0031662 | positive regulation of cyclin-dependent protein kinase activity involved in G2/M | 1.056284e-2 |
GO:0070194 | synaptonemal complex disassembly | 1.056284e-2 |
GO:2001044 | regulation of integrin-mediated signaling pathway | 1.070065e-2 |
GO:0042376 | phylloquinone catabolic process | 1.070065e-2 |
GO:0016191 | synaptic vesicle uncoating | 1.070065e-2 |
GO:0006741 | NADP biosynthetic process | 1.070065e-2 |
GO:0071899 | negative regulation of estrogen receptor binding | 1.070073e-2 |
GO:0043501 | skeletal muscle adaptation | 1.080406e-2 |
GO:0071472 | cellular response to salt stress | 1.083910e-2 |
GO:0000733 | DNA strand renaturation | 1.083910e-2 |
GO:0032232 | negative regulation of actin filament bundle assembly | 1.087839e-2 |
GO:0043570 | maintenance of DNA repeat elements | 1.093591e-2 |
GO:0043616 | keratinocyte proliferation | 1.095286e-2 |
GO:0051580 | regulation of neurotransmitter uptake | 1.095726e-2 |
GO:0021540 | corpus callosum morphogenesis | 1.101446e-2 |
GO:0051660 | establishment of centrosome localization | 1.101446e-2 |
GO:0060711 | labyrinthine layer development | 1.111121e-2 |
GO:0043966 | histone H3 acetylation | 1.112758e-2 |
GO:0035378 | carbon dioxide transmembrane transport | 1.113830e-2 |
GO:0043418 | homocysteine catabolic process | 1.113830e-2 |
GO:0035377 | transepithelial water transport | 1.113830e-2 |
GO:0085018 | maintenance of symbiont-containing vacuole via substance secreted by host | 1.113830e-2 |
GO:0019343 | cysteine biosynthetic process via cystathionine | 1.113830e-2 |
GO:0030950 | establishment or maintenance of actin cytoskeleton polarity | 1.113830e-2 |
GO:0006535 | cysteine biosynthetic process from serine | 1.113830e-2 |
GO:0019346 | transsulfuration | 1.113830e-2 |
GO:0006382 | adenosine to inosine editing | 1.152335e-2 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 1.159593e-2 |
GO:0001569 | patterning of blood vessels | 1.160161e-2 |
GO:0060350 | endochondral bone morphogenesis | 1.165303e-2 |
GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 1.182562e-2 |
GO:0014015 | positive regulation of gliogenesis | 1.202263e-2 |
GO:0090403 | oxidative stress-induced premature senescence | 1.217438e-2 |
GO:0090085 | regulation of protein deubiquitination | 1.217438e-2 |
GO:0050847 | progesterone receptor signaling pathway | 1.220651e-2 |
GO:0023041 | neuronal signal transduction | 1.224246e-2 |
GO:0060023 | soft palate development | 1.224422e-2 |
GO:0055089 | fatty acid homeostasis | 1.227887e-2 |
GO:0006105 | succinate metabolic process | 1.238138e-2 |
GO:0070092 | regulation of glucagon secretion | 1.238423e-2 |
GO:0006402 | mRNA catabolic process | 1.254850e-2 |
GO:0030826 | regulation of cGMP biosynthetic process | 1.258545e-2 |
GO:0009133 | nucleoside diphosphate biosynthetic process | 1.265357e-2 |
GO:0043585 | nose morphogenesis | 1.265357e-2 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 1.268427e-2 |
GO:0061099 | negative regulation of protein tyrosine kinase activity | 1.322656e-2 |
GO:0032956 | regulation of actin cytoskeleton organization | 1.322776e-2 |
GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity | 1.328903e-2 |
GO:0006657 | CDP-choline pathway | 1.328903e-2 |
GO:0097091 | synaptic vesicle clustering | 1.337062e-2 |
GO:0045606 | positive regulation of epidermal cell differentiation | 1.338801e-2 |
GO:0071480 | cellular response to gamma radiation | 1.359347e-2 |
GO:0071956 | cellular component maintenance at cellular level | 1.369300e-2 |
GO:0070670 | response to interleukin-4 | 1.370831e-2 |
GO:0060349 | bone morphogenesis | 1.372045e-2 |
GO:0006298 | mismatch repair | 1.379537e-2 |
GO:0060713 | labyrinthine layer morphogenesis | 1.383820e-2 |
GO:0043587 | tongue morphogenesis | 1.385778e-2 |
GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity | 1.386338e-2 |
GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity | 1.387819e-2 |
GO:0048240 | sperm capacitation | 1.388936e-2 |
GO:0060580 | ventral spinal cord interneuron fate determination | 1.391609e-2 |
GO:0003327 | type B pancreatic cell fate commitment | 1.391609e-2 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 1.407752e-2 |
GO:0051099 | positive regulation of binding | 1.417200e-2 |
GO:0045616 | regulation of keratinocyte differentiation | 1.427834e-2 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 1.437509e-2 |
GO:0006797 | polyphosphate metabolic process | 1.441672e-2 |
GO:0015919 | peroxisomal membrane transport | 1.441672e-2 |
GO:0042503 | tyrosine phosphorylation of Stat3 protein | 1.443211e-2 |
GO:0031532 | actin cytoskeleton reorganization | 1.444956e-2 |
GO:2000108 | positive regulation of leukocyte apoptosis | 1.448027e-2 |
GO:0007549 | dosage compensation | 1.458985e-2 |
GO:0006560 | proline metabolic process | 1.476144e-2 |
GO:0071205 | protein localization to juxtaparanode region of axon | 1.486823e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0016579 | protein deubiquitination | 1.112782e-37 |
GO:0070646 | protein modification by small protein removal | 8.678876e-34 |
GO:0070647 | protein modification by small protein conjugation or removal | 1.790465e-16 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 4.487770e-11 |
GO:0051865 | protein autoubiquitination | 1.419322e-10 |
GO:0034442 | regulation of lipoprotein oxidation | 2.646448e-10 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 5.907652e-9 |
GO:0033344 | cholesterol efflux | 4.023425e-8 |
GO:0046032 | ADP catabolic process | 1.062568e-7 |
GO:0046709 | IDP catabolic process | 1.062568e-7 |
GO:0050746 | regulation of lipoprotein metabolic process | 1.321818e-7 |
GO:0070193 | synaptonemal complex organization | 1.376354e-7 |
GO:0010896 | regulation of triglyceride catabolic process | 1.430183e-7 |
GO:0021797 | forebrain anterior/posterior pattern specification | 1.661094e-7 |
GO:0050994 | regulation of lipid catabolic process | 2.938952e-7 |
GO:0018279 | protein N-linked glycosylation via asparagine | 3.797668e-7 |
GO:0001887 | selenium compound metabolic process | 4.953901e-7 |
GO:0046929 | negative regulation of neurotransmitter secretion | 1.127217e-6 |
GO:0046031 | ADP metabolic process | 1.410338e-6 |
GO:0072166 | posterior mesonephric tubule development | 1.549297e-6 |
GO:0007129 | synapsis | 1.995260e-6 |
GO:0070192 | chromosome organization involved in meiosis | 2.144463e-6 |
GO:0031133 | regulation of axon diameter | 2.824929e-6 |
GO:0042304 | regulation of fatty acid biosynthetic process | 3.462650e-6 |
GO:0010898 | positive regulation of triglyceride catabolic process | 4.112847e-6 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 4.333208e-6 |
GO:0016082 | synaptic vesicle priming | 4.350637e-6 |
GO:0043932 | ossification involved in bone remodeling | 5.754325e-6 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 7.074438e-6 |
GO:0032536 | regulation of cell projection size | 7.288839e-6 |
GO:0002036 | regulation of L-glutamate transport | 7.477210e-6 |
GO:0006601 | creatine biosynthetic process | 8.103935e-6 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 8.799893e-6 |
GO:0006982 | response to lipid hydroperoxide | 1.032615e-5 |
GO:0060674 | placenta blood vessel development | 1.176178e-5 |
GO:0006342 | chromatin silencing | 1.212223e-5 |
GO:2001076 | positive regulation of metanephric ureteric bud development | 1.332516e-5 |
GO:0007356 | thorax and anterior abdomen determination | 1.332516e-5 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 1.332516e-5 |
GO:0008616 | queuosine biosynthetic process | 1.445581e-5 |
GO:0072500 | negative regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 1.735640e-5 |
GO:0051026 | chiasma assembly | 1.737120e-5 |
GO:0032849 | positive regulation of cellular pH reduction | 1.795044e-5 |
GO:0065005 | protein-lipid complex assembly | 1.798932e-5 |
GO:0006344 | maintenance of chromatin silencing | 1.820822e-5 |
GO:0045046 | protein import into peroxisome membrane | 1.837551e-5 |
GO:0006188 | IMP biosynthetic process | 2.804581e-5 |
GO:0007130 | synaptonemal complex assembly | 2.880048e-5 |
GO:0090177 | establishment of planar polarity involved in neural tube closure | 2.917096e-5 |
GO:0021516 | dorsal spinal cord development | 3.231625e-5 |
GO:0035021 | negative regulation of Rac protein signal transduction | 4.164515e-5 |
GO:0007354 | zygotic determination of anterior/posterior axis, embryo | 4.264503e-5 |
GO:0090140 | regulation of mitochondrial fission | 4.425364e-5 |
GO:0008617 | guanosine metabolic process | 4.425364e-5 |
GO:0050995 | negative regulation of lipid catabolic process | 4.681392e-5 |
GO:0033127 | regulation of histone phosphorylation | 4.754345e-5 |
GO:0045922 | negative regulation of fatty acid metabolic process | 5.120147e-5 |
GO:0090083 | regulation of inclusion body assembly | 5.385473e-5 |
GO:0021528 | commissural neuron differentiation in spinal cord | 5.983626e-5 |
GO:0021965 | spinal cord ventral commissure morphogenesis | 6.697514e-5 |
GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase | 6.850525e-5 |
GO:0009088 | threonine biosynthetic process | 7.156957e-5 |
GO:0032648 | regulation of interferon-beta production | 7.676113e-5 |
GO:0051168 | nuclear export | 8.549030e-5 |
GO:0006189 | 'de novo' IMP biosynthetic process | 9.064636e-5 |
GO:0006290 | pyrimidine dimer repair | 9.401064e-5 |
GO:0060716 | labyrinthine layer blood vessel development | 1.027075e-4 |
GO:0051004 | regulation of lipoprotein lipase activity | 1.055663e-4 |
GO:0032312 | regulation of ARF GTPase activity | 1.090303e-4 |
GO:0070265 | necrotic cell death | 1.096859e-4 |
GO:0045109 | intermediate filament organization | 1.146153e-4 |
GO:0042249 | establishment of planar polarity of embryonic epithelium | 1.221345e-4 |
GO:0008088 | axon cargo transport | 1.253955e-4 |
GO:0045787 | positive regulation of cell cycle | 1.271306e-4 |
GO:0090141 | positive regulation of mitochondrial fission | 1.430463e-4 |
GO:0009179 | purine ribonucleoside diphosphate metabolic process | 1.461773e-4 |
GO:0002701 | negative regulation of production of molecular mediator of immune response | 1.556138e-4 |
GO:0002227 | innate immune response in mucosa | 1.625371e-4 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 1.649275e-4 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 1.701811e-4 |
GO:0031440 | regulation of mRNA 3'-end processing | 1.709394e-4 |
GO:0002467 | germinal center formation | 1.736565e-4 |
GO:0035249 | synaptic transmission, glutamatergic | 1.817160e-4 |
GO:0071816 | tail-anchored membrane protein insertion into ER membrane | 1.888739e-4 |
GO:0043303 | mast cell degranulation | 1.896015e-4 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.966680e-4 |
GO:0021776 | smoothened signaling pathway involved in spinal cord motor neuron cell fate specification | 2.027521e-4 |
GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification | 2.027521e-4 |
GO:0043299 | leukocyte degranulation | 2.030664e-4 |
GO:0043243 | positive regulation of protein complex disassembly | 2.143121e-4 |
GO:0030259 | lipid glycosylation | 2.147174e-4 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 2.165472e-4 |
GO:0016068 | type I hypersensitivity | 2.165472e-4 |
GO:0006825 | copper ion transport | 2.384301e-4 |
GO:0009134 | nucleoside diphosphate catabolic process | 2.554521e-4 |
GO:0043691 | reverse cholesterol transport | 2.564675e-4 |
GO:0051956 | negative regulation of amino acid transport | 2.627990e-4 |
GO:0046889 | positive regulation of lipid biosynthetic process | 2.759340e-4 |
GO:0090281 | negative regulation of calcium ion import | 2.915169e-4 |
GO:0071584 | negative regulation of zinc ion import | 2.915169e-4 |
GO:0015788 | UDP-N-acetylglucosamine transport | 2.915169e-4 |
GO:0015790 | UDP-xylose transport | 2.915169e-4 |
GO:0070885 | negative regulation of calcineurin-NFAT signaling pathway | 2.915169e-4 |
GO:0045429 | positive regulation of nitric oxide biosynthetic process | 3.050194e-4 |
GO:0051583 | dopamine uptake | 3.053833e-4 |
GO:0001555 | oocyte growth | 3.127084e-4 |
GO:0008156 | negative regulation of DNA replication | 3.159644e-4 |
GO:0009181 | purine ribonucleoside diphosphate catabolic process | 3.308342e-4 |
GO:0070936 | protein K48-linked ubiquitination | 3.392809e-4 |
GO:0032513 | negative regulation of protein phosphatase type 2B activity | 3.493832e-4 |
GO:0016191 | synaptic vesicle uncoating | 3.493832e-4 |
GO:0046580 | negative regulation of Ras protein signal transduction | 3.559877e-4 |
GO:0060712 | spongiotrophoblast layer development | 3.722225e-4 |
GO:0034405 | response to fluid shear stress | 3.771167e-4 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 3.903369e-4 |
GO:0023021 | termination of signal transduction | 4.214955e-4 |
GO:0045055 | regulated secretory pathway | 4.570300e-4 |
GO:0006878 | cellular copper ion homeostasis | 4.598615e-4 |
GO:0060896 | neural plate pattern specification | 4.811292e-4 |
GO:0070585 | protein localization in mitochondrion | 4.982397e-4 |
GO:0002155 | regulation of thyroid hormone mediated signaling pathway | 5.089570e-4 |
GO:0035094 | response to nicotine | 5.160412e-4 |
GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane | 5.363048e-4 |
GO:0021997 | neural plate axis specification | 5.363048e-4 |
GO:0045428 | regulation of nitric oxide biosynthetic process | 5.510617e-4 |
GO:0000904 | cell morphogenesis involved in differentiation | 5.900050e-4 |
GO:0035404 | histone-serine phosphorylation | 6.026387e-4 |
GO:0021954 | central nervous system neuron development | 6.100002e-4 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 6.131895e-4 |
GO:0031929 | TOR signaling cascade | 6.150464e-4 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 6.155584e-4 |
GO:0006406 | mRNA export from nucleus | 6.180507e-4 |
GO:0051058 | negative regulation of small GTPase mediated signal transduction | 6.441842e-4 |
GO:2000143 | negative regulation of transcription initiation, DNA-dependent | 6.763572e-4 |
GO:0045085 | negative regulation of interleukin-2 biosynthetic process | 6.763572e-4 |
GO:0032728 | positive regulation of interferon-beta production | 7.026224e-4 |
GO:0060052 | neurofilament cytoskeleton organization | 7.179990e-4 |
GO:0009817 | defense response to fungus, incompatible interaction | 7.198267e-4 |
GO:0043623 | cellular protein complex assembly | 7.263804e-4 |
GO:0010970 | microtubule-based transport | 7.368943e-4 |
GO:0010936 | negative regulation of macrophage cytokine production | 7.415373e-4 |
GO:0072268 | pattern specification involved in metanephros development | 7.415373e-4 |
GO:0044243 | multicellular organismal catabolic process | 7.578406e-4 |
GO:0033700 | phospholipid efflux | 7.717587e-4 |
GO:0042994 | cytoplasmic sequestering of transcription factor | 7.816797e-4 |
GO:0046322 | negative regulation of fatty acid oxidation | 8.032311e-4 |
GO:0002385 | mucosal immune response | 8.079380e-4 |
GO:0045875 | negative regulation of sister chromatid cohesion | 8.300364e-4 |
GO:0045925 | positive regulation of female receptivity | 8.781164e-4 |
GO:0051481 | reduction of cytosolic calcium ion concentration | 8.888522e-4 |
GO:0006654 | phosphatidic acid biosynthetic process | 9.342717e-4 |
GO:0060997 | dendritic spine morphogenesis | 9.777377e-4 |
GO:0046890 | regulation of lipid biosynthetic process | 9.808836e-4 |
GO:0060711 | labyrinthine layer development | 1.018581e-3 |
GO:0071316 | cellular response to nicotine | 1.059657e-3 |
GO:2000273 | positive regulation of receptor activity | 1.083701e-3 |
GO:0019217 | regulation of fatty acid metabolic process | 1.084594e-3 |
GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning | 1.085870e-3 |
GO:0006098 | pentose-phosphate shunt | 1.119146e-3 |
GO:0030573 | bile acid catabolic process | 1.152254e-3 |
GO:0002125 | maternal aggressive behavior | 1.152254e-3 |
GO:0010845 | positive regulation of reciprocal meiotic recombination | 1.152254e-3 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 1.153998e-3 |
GO:0097151 | positive regulation of inhibitory postsynaptic membrane potential | 1.156595e-3 |
GO:0007630 | jump response | 1.156595e-3 |
GO:0001966 | thigmotaxis | 1.156595e-3 |
GO:0061005 | cell differentiation involved in kidney development | 1.188757e-3 |
GO:0021542 | dentate gyrus development | 1.193649e-3 |
GO:0043320 | natural killer cell degranulation | 1.197432e-3 |
GO:0045040 | protein import into mitochondrial outer membrane | 1.210582e-3 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 1.235864e-3 |
GO:0042992 | negative regulation of transcription factor import into nucleus | 1.235946e-3 |
GO:0051299 | centrosome separation | 1.302128e-3 |
GO:0009191 | ribonucleoside diphosphate catabolic process | 1.302777e-3 |
GO:0009952 | anterior/posterior pattern specification | 1.346859e-3 |
GO:0045750 | positive regulation of S phase of mitotic cell cycle | 1.364895e-3 |
GO:0044091 | membrane biogenesis | 1.376409e-3 |
GO:0019367 | fatty acid elongation, saturated fatty acid | 1.376409e-3 |
GO:0045814 | negative regulation of gene expression, epigenetic | 1.413706e-3 |
GO:0071557 | histone H3-K27 demethylation | 1.442425e-3 |
GO:0035574 | histone H4-K20 demethylation | 1.442425e-3 |
GO:0033128 | negative regulation of histone phosphorylation | 1.442425e-3 |
GO:0031329 | regulation of cellular catabolic process | 1.442759e-3 |
GO:0071593 | lymphocyte aggregation | 1.443524e-3 |
GO:0060923 | cardiac muscle cell fate commitment | 1.457951e-3 |
GO:0006405 | RNA export from nucleus | 1.483223e-3 |
GO:0046885 | regulation of hormone biosynthetic process | 1.515320e-3 |
GO:0051897 | positive regulation of protein kinase B signaling cascade | 1.518996e-3 |
GO:0060125 | negative regulation of growth hormone secretion | 1.530043e-3 |
GO:0051463 | negative regulation of cortisol secretion | 1.530043e-3 |
GO:2000009 | negative regulation of protein localization at cell surface | 1.530043e-3 |
GO:0007057 | spindle assembly involved in female meiosis I | 1.530043e-3 |
GO:0021933 | radial glia guided migration of cerebellar granule cell | 1.530043e-3 |
GO:0021703 | locus ceruleus development | 1.530043e-3 |
GO:0090303 | positive regulation of wound healing | 1.555498e-3 |
GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning | 1.555498e-3 |
GO:0003002 | regionalization | 1.573426e-3 |
GO:0006513 | protein monoubiquitination | 1.609551e-3 |
GO:0002062 | chondrocyte differentiation | 1.618619e-3 |
GO:0055070 | copper ion homeostasis | 1.620972e-3 |
GO:0002251 | organ or tissue specific immune response | 1.620972e-3 |
GO:0032479 | regulation of type I interferon production | 1.706188e-3 |
GO:0000422 | mitochondrion degradation | 1.744212e-3 |
GO:0042396 | phosphagen biosynthetic process | 1.744212e-3 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 1.768593e-3 |
GO:0002719 | negative regulation of cytokine production involved in immune response | 1.811419e-3 |
GO:0045862 | positive regulation of proteolysis | 1.831574e-3 |
GO:0071585 | detoxification of cadmium ion | 1.834043e-3 |
GO:0044240 | multicellular organismal lipid catabolic process | 1.843074e-3 |
GO:0010984 | regulation of lipoprotein particle clearance | 1.868109e-3 |
GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly | 1.873369e-3 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 1.873369e-3 |
GO:0030300 | regulation of intestinal cholesterol absorption | 1.896236e-3 |
GO:0032847 | regulation of cellular pH reduction | 1.901125e-3 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 1.909357e-3 |
GO:0090084 | negative regulation of inclusion body assembly | 1.935826e-3 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 1.936321e-3 |
GO:0051258 | protein polymerization | 1.999572e-3 |
GO:0006611 | protein export from nucleus | 2.008012e-3 |
GO:0050849 | negative regulation of calcium-mediated signaling | 2.118934e-3 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 2.175840e-3 |
GO:0070169 | positive regulation of biomineral tissue development | 2.181974e-3 |
GO:0070831 | basement membrane assembly | 2.222748e-3 |
GO:0032203 | telomere formation via telomerase | 2.222748e-3 |
GO:0021547 | midbrain-hindbrain boundary initiation | 2.275142e-3 |
GO:0021501 | prechordal plate formation | 2.275142e-3 |
GO:0051017 | actin filament bundle assembly | 2.333057e-3 |
GO:0060266 | negative regulation of respiratory burst involved in inflammatory response | 2.375894e-3 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 2.375894e-3 |
GO:0045994 | positive regulation of translational initiation by iron | 2.375894e-3 |
GO:0002037 | negative regulation of L-glutamate transport | 2.375894e-3 |
GO:0006540 | glutamate decarboxylation to succinate | 2.375894e-3 |
GO:0034116 | positive regulation of heterotypic cell-cell adhesion | 2.375894e-3 |
GO:0021539 | subthalamus development | 2.378503e-3 |
GO:0070076 | histone lysine demethylation | 2.400651e-3 |
GO:0001886 | endothelial cell morphogenesis | 2.412581e-3 |
GO:0055012 | ventricular cardiac muscle cell differentiation | 2.461492e-3 |
GO:0034619 | cellular chaperone-mediated protein complex assembly | 2.483025e-3 |
GO:0031536 | positive regulation of exit from mitosis | 2.604168e-3 |
GO:0019227 | neuronal action potential propagation | 2.642547e-3 |
GO:0035434 | copper ion transmembrane transport | 2.642547e-3 |
GO:0031103 | axon regeneration | 2.722824e-3 |
GO:0031102 | neuron projection regeneration | 2.802419e-3 |
GO:0035802 | adrenal cortex formation | 2.803097e-3 |
GO:0034259 | negative regulation of Rho GTPase activity | 2.886752e-3 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 3.007853e-3 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 3.071717e-3 |
GO:0007521 | muscle cell fate determination | 3.071717e-3 |
GO:0001963 | synaptic transmission, dopaminergic | 3.096478e-3 |
GO:0045176 | apical protein localization | 3.111379e-3 |
GO:0031331 | positive regulation of cellular catabolic process | 3.152905e-3 |
GO:0045103 | intermediate filament-based process | 3.317532e-3 |
GO:0046886 | positive regulation of hormone biosynthetic process | 3.337929e-3 |
GO:0030501 | positive regulation of bone mineralization | 3.345866e-3 |
GO:0007389 | pattern specification process | 3.387915e-3 |
GO:0042308 | negative regulation of protein import into nucleus | 3.406145e-3 |
GO:0046928 | regulation of neurotransmitter secretion | 3.412317e-3 |
GO:2000286 | receptor internalization involved in canonical Wnt receptor signaling pathway | 3.455539e-3 |
GO:0015862 | uridine transport | 3.455539e-3 |
GO:0009296 | flagellum assembly | 3.465167e-3 |
GO:0051588 | regulation of neurotransmitter transport | 3.619554e-3 |
GO:0051298 | centrosome duplication | 3.631676e-3 |
GO:0010893 | positive regulation of steroid biosynthetic process | 3.650517e-3 |
GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 3.650742e-3 |
GO:0070884 | regulation of calcineurin-NFAT signaling pathway | 3.650742e-3 |
GO:0022417 | protein maturation by protein folding | 3.650742e-3 |
GO:0015781 | pyrimidine nucleotide-sugar transport | 3.650742e-3 |
GO:0043153 | entrainment of circadian clock by photoperiod | 3.737510e-3 |
GO:0035583 | negative regulation of transforming growth factor beta receptor signaling pathway by extracellular sequestering of TGFbeta | 3.737510e-3 |
GO:0072655 | establishment of protein localization in mitochondrion | 3.780770e-3 |
GO:0006198 | cAMP catabolic process | 3.781755e-3 |
GO:0014012 | peripheral nervous system axon regeneration | 3.889251e-3 |
GO:2000178 | negative regulation of neural precursor cell proliferation | 3.901452e-3 |
GO:0031508 | centromeric heterochromatin formation | 3.926969e-3 |
GO:0000189 | MAPK import into nucleus | 3.926969e-3 |
GO:0021837 | motogenic signaling involved in postnatal olfactory bulb interneuron migration | 3.926969e-3 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 3.939780e-3 |
GO:0045585 | positive regulation of cytotoxic T cell differentiation | 3.940372e-3 |
GO:0045110 | intermediate filament bundle assembly | 3.940372e-3 |
GO:0006699 | bile acid biosynthetic process | 3.959008e-3 |
GO:0003347 | epicardial cell to mesenchymal cell transition | 3.959008e-3 |
GO:0071803 | positive regulation of podosome assembly | 3.962744e-3 |
GO:0031584 | activation of phospholipase D activity | 3.962744e-3 |
GO:0006414 | translational elongation | 3.974837e-3 |
GO:0045579 | positive regulation of B cell differentiation | 4.020586e-3 |
GO:0061032 | visceral serous pericardium development | 4.231446e-3 |
GO:0006913 | nucleocytoplasmic transport | 4.251605e-3 |
GO:0034382 | chylomicron remnant clearance | 4.329090e-3 |
GO:0060996 | dendritic spine development | 4.329898e-3 |
GO:0060193 | positive regulation of lipase activity | 4.381111e-3 |
GO:0032383 | regulation of intracellular cholesterol transport | 4.437417e-3 |
GO:0001811 | negative regulation of type I hypersensitivity | 4.437417e-3 |
GO:0002638 | negative regulation of immunoglobulin production | 4.437417e-3 |
GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | 4.506964e-3 |
GO:0045401 | positive regulation of interleukin-3 biosynthetic process | 4.506964e-3 |
GO:0035850 | epithelial cell differentiation involved in kidney development | 4.542403e-3 |
GO:0030500 | regulation of bone mineralization | 4.643493e-3 |
GO:0070574 | cadmium ion transmembrane transport | 4.731391e-3 |
GO:0070301 | cellular response to hydrogen peroxide | 4.806165e-3 |
GO:0006184 | GTP catabolic process | 4.853012e-3 |
GO:0046784 | intronless viral mRNA export from host nucleus | 4.952720e-3 |
GO:0043467 | regulation of generation of precursor metabolites and energy | 4.960908e-3 |
GO:0060421 | positive regulation of heart growth | 4.982281e-3 |
GO:0050711 | negative regulation of interleukin-1 secretion | 4.982281e-3 |
GO:0035444 | nickel ion transmembrane transport | 5.078955e-3 |
GO:0007060 | male meiosis chromosome segregation | 5.078955e-3 |
GO:0001539 | ciliary or flagellar motility | 5.105247e-3 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 5.114221e-3 |
GO:0021871 | forebrain regionalization | 5.129964e-3 |
GO:0045723 | positive regulation of fatty acid biosynthetic process | 5.274369e-3 |
GO:2000195 | negative regulation of female gonad development | 5.423390e-3 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 5.437216e-3 |
GO:0045576 | mast cell activation | 5.474013e-3 |
GO:0072284 | metanephric S-shaped body morphogenesis | 5.480687e-3 |
GO:0072278 | metanephric comma-shaped body morphogenesis | 5.480687e-3 |
GO:0010897 | negative regulation of triglyceride catabolic process | 5.480687e-3 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 5.480687e-3 |
GO:0042711 | maternal behavior | 5.540751e-3 |
GO:0034770 | histone H4-K20 methylation | 5.540751e-3 |
GO:0046128 | purine ribonucleoside metabolic process | 5.562862e-3 |
GO:0009648 | photoperiodism | 5.649164e-3 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 5.649164e-3 |
GO:0007095 | mitotic cell cycle G2/M transition DNA damage checkpoint | 5.996052e-3 |
GO:0043064 | flagellum organization | 6.024214e-3 |
GO:0070167 | regulation of biomineral tissue development | 6.130534e-3 |
GO:0000209 | protein polyubiquitination | 6.142318e-3 |
GO:0006626 | protein targeting to mitochondrion | 6.245132e-3 |
GO:0045423 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | 6.321885e-3 |
GO:0015864 | pyrimidine nucleoside transport | 6.321885e-3 |
GO:0045737 | positive regulation of cyclin-dependent protein kinase activity | 6.347381e-3 |
GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore | 6.439892e-3 |
GO:0071624 | positive regulation of granulocyte chemotaxis | 6.439892e-3 |
GO:0030150 | protein import into mitochondrial matrix | 6.439892e-3 |
GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation | 6.439892e-3 |
GO:0019290 | siderophore biosynthetic process | 6.439892e-3 |
GO:0002418 | immune response to tumor cell | 6.439892e-3 |
GO:0010157 | response to chlorate | 6.524074e-3 |
GO:0006931 | substrate-dependent cell migration, cell attachment to substrate | 6.524074e-3 |
GO:0042760 | very long-chain fatty acid catabolic process | 6.558976e-3 |
GO:0045175 | basal protein localization | 6.565645e-3 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 6.649942e-3 |
GO:0051169 | nuclear transport | 6.733311e-3 |
GO:0045940 | positive regulation of steroid metabolic process | 6.822706e-3 |
GO:0060191 | regulation of lipase activity | 6.929160e-3 |
GO:0006475 | internal protein amino acid acetylation | 6.933250e-3 |
GO:0090068 | positive regulation of cell cycle process | 6.967303e-3 |
GO:0007288 | sperm axoneme assembly | 7.005835e-3 |
GO:2000822 | regulation of behavioral fear response | 7.096020e-3 |
GO:0045116 | protein neddylation | 7.114923e-3 |
GO:0043457 | regulation of cellular respiration | 7.114923e-3 |
GO:0061181 | regulation of chondrocyte development | 7.249637e-3 |
GO:2000744 | positive regulation of anterior head development | 7.249637e-3 |
GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity | 7.249637e-3 |
GO:0060028 | convergent extension involved in axis elongation | 7.249637e-3 |
GO:0019049 | evasion of host defenses by virus | 7.429167e-3 |
GO:0032713 | negative regulation of interleukin-4 production | 7.683158e-3 |
GO:0071279 | cellular response to cobalt ion | 7.736607e-3 |
GO:0070370 | cellular heat acclimation | 7.736607e-3 |
GO:0010637 | negative regulation of mitochondrial fusion | 7.736607e-3 |
GO:0043048 | dolichyl monophosphate biosynthetic process | 7.736607e-3 |
GO:0018960 | 4-nitrophenol metabolic process | 7.736607e-3 |
GO:0060011 | Sertoli cell proliferation | 7.767609e-3 |
GO:0006102 | isocitrate metabolic process | 7.767609e-3 |
GO:0048050 | post-embryonic eye morphogenesis | 7.767609e-3 |
GO:0000902 | cell morphogenesis | 7.863556e-3 |
GO:0090231 | regulation of spindle checkpoint | 7.925888e-3 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 7.942185e-3 |
GO:0060021 | palate development | 7.974485e-3 |
GO:0016079 | synaptic vesicle exocytosis | 7.999649e-3 |
GO:0032202 | telomere assembly | 8.244566e-3 |
GO:0006868 | glutamine transport | 8.251713e-3 |
GO:0034720 | histone H3-K4 demethylation | 8.388860e-3 |
GO:0007281 | germ cell development | 8.569011e-3 |
GO:0046006 | regulation of activated T cell proliferation | 8.630542e-3 |
GO:0002513 | tolerance induction to self antigen | 8.667745e-3 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 8.667745e-3 |
GO:0002248 | connective tissue replacement involved in inflammatory response wound healing | 8.768947e-3 |
GO:0034616 | response to laminar fluid shear stress | 8.769595e-3 |
GO:0046058 | cAMP metabolic process | 8.918873e-3 |
GO:0072594 | establishment of protein localization to organelle | 8.976500e-3 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 9.134396e-3 |
GO:0072521 | purine-containing compound metabolic process | 9.156378e-3 |
GO:0051131 | chaperone-mediated protein complex assembly | 9.202727e-3 |
GO:0060555 | induction of necroptosis by extracellular signals | 9.202727e-3 |
GO:0060489 | planar dichotomous subdivision of terminal units involved in lung branching morphogenesis | 9.261646e-3 |
GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis | 9.261646e-3 |
GO:0060490 | lateral sprouting involved in lung morphogenesis | 9.261646e-3 |
GO:0048105 | establishment of body hair planar orientation | 9.261646e-3 |
GO:0043697 | cell dedifferentiation | 9.261646e-3 |
GO:0046831 | regulation of RNA export from nucleus | 9.261646e-3 |
GO:0045104 | intermediate filament cytoskeleton organization | 9.283864e-3 |
GO:0034614 | cellular response to reactive oxygen species | 9.305940e-3 |
GO:0060259 | regulation of feeding behavior | 9.322498e-3 |
GO:0044058 | regulation of digestive system process | 9.406241e-3 |
GO:0033146 | regulation of estrogen receptor signaling pathway | 9.470498e-3 |
GO:0090030 | regulation of steroid hormone biosynthetic process | 9.572066e-3 |
GO:0006600 | creatine metabolic process | 9.639621e-3 |
GO:0071827 | plasma lipoprotein particle organization | 9.877510e-3 |
GO:0071711 | basement membrane organization | 9.879514e-3 |
GO:0000185 | activation of MAPKKK activity | 9.879514e-3 |
GO:0006436 | tryptophanyl-tRNA aminoacylation | 9.885630e-3 |
GO:0033211 | adiponectin-mediated signaling pathway | 9.899631e-3 |
GO:0035470 | positive regulation of vascular wound healing | 9.905454e-3 |
GO:0060821 | inactivation of X chromosome by DNA methylation | 9.905454e-3 |
GO:0045751 | negative regulation of Toll signaling pathway | 9.905454e-3 |
GO:0010616 | negative regulation of cardiac muscle adaptation | 9.905454e-3 |
GO:0019428 | allantoin biosynthetic process | 9.905454e-3 |
GO:0019858 | cytosine metabolic process | 9.905454e-3 |
GO:0018393 | internal peptidyl-lysine acetylation | 9.964335e-3 |
GO:0032446 | protein modification by small protein conjugation | 1.009113e-2 |
GO:0035562 | negative regulation of chromatin binding | 1.020903e-2 |
GO:0014053 | negative regulation of gamma-aminobutyric acid secretion | 1.020903e-2 |
GO:0033129 | positive regulation of histone phosphorylation | 1.020903e-2 |
GO:0015891 | siderophore transport | 1.020903e-2 |
GO:0034508 | centromere complex assembly | 1.043113e-2 |
GO:0006536 | glutamate metabolic process | 1.044364e-2 |
GO:0016567 | protein ubiquitination | 1.058471e-2 |
GO:0032352 | positive regulation of hormone metabolic process | 1.078892e-2 |
GO:0072015 | glomerular visceral epithelial cell development | 1.087050e-2 |
GO:0031394 | positive regulation of prostaglandin biosynthetic process | 1.090712e-2 |
GO:0032472 | Golgi calcium ion transport | 1.090854e-2 |
GO:0050760 | negative regulation of thymidylate synthase biosynthetic process | 1.090854e-2 |
GO:0042938 | dipeptide transport | 1.090854e-2 |
GO:0032468 | Golgi calcium ion homeostasis | 1.090854e-2 |
GO:0030026 | cellular manganese ion homeostasis | 1.090854e-2 |
GO:0009150 | purine ribonucleotide metabolic process | 1.098467e-2 |
GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination | 1.102068e-2 |
GO:0002001 | renin secretion into blood stream | 1.102068e-2 |
GO:0032318 | regulation of Ras GTPase activity | 1.104628e-2 |
GO:0031507 | heterochromatin formation | 1.113042e-2 |
GO:0045948 | positive regulation of translational initiation | 1.121045e-2 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.138936e-2 |
GO:0007044 | cell-substrate junction assembly | 1.144784e-2 |
GO:0038007 | netrin-activated signaling pathway | 1.163932e-2 |
GO:0060696 | regulation of phospholipid catabolic process | 1.163948e-2 |
GO:0051589 | negative regulation of neurotransmitter transport | 1.163948e-2 |
GO:0051973 | positive regulation of telomerase activity | 1.166530e-2 |
GO:0042891 | antibiotic transport | 1.166530e-2 |
GO:2000300 | regulation of synaptic vesicle exocytosis | 1.174623e-2 |
GO:2000194 | regulation of female gonad development | 1.174623e-2 |
GO:0034763 | negative regulation of transmembrane transport | 1.202213e-2 |
GO:0018394 | peptidyl-lysine acetylation | 1.209304e-2 |
GO:0031330 | negative regulation of cellular catabolic process | 1.211801e-2 |
GO:0006402 | mRNA catabolic process | 1.227899e-2 |
GO:0060122 | inner ear receptor stereocilium organization | 1.228602e-2 |
GO:0006415 | translational termination | 1.242100e-2 |
GO:0060591 | chondroblast differentiation | 1.242100e-2 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.253533e-2 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 1.279958e-2 |
GO:0010469 | regulation of receptor activity | 1.301372e-2 |
GO:0090208 | positive regulation of triglyceride metabolic process | 1.323501e-2 |
GO:0051532 | regulation of NFAT protein import into nucleus | 1.330182e-2 |
GO:0007099 | centriole replication | 1.335271e-2 |
GO:0031647 | regulation of protein stability | 1.339791e-2 |
GO:0051586 | positive regulation of dopamine uptake | 1.340475e-2 |
GO:0060032 | notochord regression | 1.340475e-2 |
GO:0048667 | cell morphogenesis involved in neuron differentiation | 1.342850e-2 |
GO:0030325 | adrenal gland development | 1.347173e-2 |
GO:0050428 | 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process | 1.364476e-2 |
GO:0060557 | positive regulation of vitamin D biosynthetic process | 1.368527e-2 |
GO:0044154 | histone H3-K14 acetylation | 1.368527e-2 |
GO:0072531 | pyrimidine-containing compound transmembrane transport | 1.384171e-2 |
GO:0031017 | exocrine pancreas development | 1.397832e-2 |
GO:0009954 | proximal/distal pattern formation | 1.438742e-2 |
GO:0032481 | positive regulation of type I interferon production | 1.444376e-2 |
GO:0045931 | positive regulation of mitotic cell cycle | 1.486105e-2 |
GO:0060119 | inner ear receptor cell development | 1.508144e-2 |
GO:0034377 | plasma lipoprotein particle assembly | 1.512848e-2 |
GO:0046039 | GTP metabolic process | 1.515385e-2 |
GO:0051382 | kinetochore assembly | 1.523467e-2 |
GO:0035520 | monoubiquitinated protein deubiquitination | 1.523467e-2 |
GO:0032980 | keratinocyte activation | 1.523467e-2 |
GO:0006195 | purine nucleotide catabolic process | 1.523552e-2 |
GO:0061013 | regulation of mRNA catabolic process | 1.527013e-2 |
GO:0090005 | negative regulation of establishment of protein localization in plasma membrane | 1.533451e-2 |
GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter | 1.533451e-2 |
GO:0048378 | regulation of lateral mesodermal cell fate specification | 1.533451e-2 |
GO:0000183 | chromatin silencing at rDNA | 1.537981e-2 |
GO:0048671 | negative regulation of collateral sprouting | 1.544657e-2 |
GO:0014002 | astrocyte development | 1.568579e-2 |
GO:0034369 | plasma lipoprotein particle remodeling | 1.589993e-2 |
GO:0031999 | negative regulation of fatty acid beta-oxidation | 1.605620e-2 |
GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus | 1.605620e-2 |
GO:0008105 | asymmetric protein localization | 1.615237e-2 |
GO:0042136 | neurotransmitter biosynthetic process | 1.625911e-2 |
GO:0071352 | cellular response to interleukin-2 | 1.628707e-2 |
GO:2000653 | regulation of genetic imprinting | 1.628707e-2 |
GO:0065002 | intracellular protein transmembrane transport | 1.628707e-2 |
GO:0046604 | positive regulation of mitotic centrosome separation | 1.628707e-2 |
GO:0002357 | defense response to tumor cell | 1.628707e-2 |
GO:0010891 | negative regulation of sequestering of triglyceride | 1.648403e-2 |
GO:0045924 | regulation of female receptivity | 1.662474e-2 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 1.663668e-2 |
GO:0002541 | activation of plasma proteins involved in acute inflammatory response | 1.700569e-2 |
GO:0015804 | neutral amino acid transport | 1.737592e-2 |
GO:0019048 | virus-host interaction | 1.747676e-2 |
GO:0045806 | negative regulation of endocytosis | 1.762050e-2 |
GO:0031581 | hemidesmosome assembly | 1.779469e-2 |
GO:0048563 | post-embryonic organ morphogenesis | 1.779469e-2 |
GO:0046607 | positive regulation of centrosome cycle | 1.839063e-2 |